Clinical Trials Logo

Sarcopenia clinical trials

View clinical trials related to Sarcopenia.

Filter by:
  • Terminated  
  • Page 1 ·  Next »

NCT ID: NCT05474157 Terminated - Covid19 Clinical Trials

Sarcopenia and Related Factors in Coronavirus Disease 2019 (COVID-19) Following Intensive Care

Start date: March 1, 2021
Phase:
Study type: Observational

The primary aim of this study is to evaluate the patients who had pneumonia or severe acute respiratory distress syndrome (ARDS) due to COVID-19 in terms of sarcopenia and related factors following Intensive Care Unit (ICU). The patients who had COVID-19 infection in the ICU and the patients who admitted to the 'Physical Medicine and Rehabilitation' clinic for other reasons during the pandemic period will be compared in terms of sarcopenia.

NCT ID: NCT04827758 Terminated - Sarcopenia Clinical Trials

Evaluation of a Screening Strategy for Sarcopenia: a Monocentric Prospective Cohort Study (STRAS)

STRAS
Start date: April 22, 2021
Phase: N/A
Study type: Interventional

The main objective of this study is to determine the prevalence of sarcopenia in patients hospitalized in the follow-up care and rehabilitation units of the geriatrics department of the Mulhouse French hospital.

NCT ID: NCT04806152 Terminated - Sarcopenia Clinical Trials

Sarcopenia and Combined-modality Exercise

Start date: May 2, 2017
Phase: N/A
Study type: Interventional

This study examined the effects of combined-modality exercise training (resistance, endurance, flexibility and balance) on muscle mass, muscle function and physical activity in community-dwelling elderly living in Jamaica who had been characterised as having sarcopenia.

NCT ID: NCT04756856 Terminated - Sarcopenia Clinical Trials

Muscle-targeted Nutritional Therapy for the Recovery From COVID-19

RE-COVID
Start date: April 21, 2021
Phase: N/A
Study type: Interventional

To assess the impact of a muscle-targeted nutritional therapy consisting of nutritional counseling and high-quality whey protein-based oral nutritional supplements enriched with leucine and vitamin D, on the recovery of post-COVID-19 patients

NCT ID: NCT04649086 Terminated - Covid19 Clinical Trials

Muscular Rehabilitation by Eccentric Exercise After Severe COVID-19 Infection

CovExc
Start date: June 5, 2020
Phase: N/A
Study type: Interventional

With the COVID-19 pandemic, the number of patients to be treated in rehabilitation increased . Hospitalization for severe infection can induce muscular atrophy and muscular dysfunction that persists for several months and rehabilitation capacities may be exceeded. Exercises in eccentric mode could be performed, inducing greater muscular hypertrophy, muscle strength, power and speed than concentric exercises. The goal of this study was to compare functional recovery at 2 months after a training program in eccentric and concentric mode after severe COVID-19. An effective rehabilitation could help reduce costs and duration of care.

NCT ID: NCT04350762 Terminated - Sarcopenia Clinical Trials

Nutritional Supplementation in the Elderly With Weight Loss

Elderly
Start date: September 5, 2019
Phase: N/A
Study type: Interventional

Many elderly experience weight loss and weakness with normal aging. Although there is extensive literature regarding nutritional advice for the elderly, there are few well- designed studies evaluating the effect of oral nutrition supplements in patients with weight loss and aging. The aim of this study is to examine the effect of dietary prescription with or without nutrition supplementation that includes soy protein, whey protein and fish oil in elderly patients who have suffered unintentional weight loss.

NCT ID: NCT04306562 Terminated - Cancer Clinical Trials

Effect of Oral Protein Supplementation on Postoperative Complications in Elderly Sarcopenic Cancerous Patients

Start date: October 1, 2019
Phase: N/A
Study type: Interventional

Sarcopenia is a condition of reduced skeletal muscle associated with aging. It leads to poor outcome and increased risk of postoperative complications. Achieving protein and energy requirements is crucial point in sarcopenia treatment. In preoperative patients, daily consumption of protein should be at least 1.2-2.0 g of protein/kg/day or 25-35 g of protein in a meal to provide muscular protein synthesis. The objective of this study is to show that preoperative enteral protein supplementation in elderly cancerous patients, who are diagnosed with sarcopenia, can decrease morbidity such as postoperative complications; mortality and improve postoperative clinical outcomes after elective surgery.

NCT ID: NCT04095533 Terminated - Sarcopenia Clinical Trials

ICU Associated Weakness and Bedside Ultrasound Assessment

Start date: October 1, 2019
Phase:
Study type: Observational

ICU-associated weakness is a common experience for people following a critical illness. It is associated with important patient and system-relevant outcomes. Diagnosing ICU-associated weakness can be challenging because making the diagnosis relies on volitional participation in strength testing by the patient in a very ill population that is often sedated or restrained. This study proposes to test if bedside ultrasound of tibialis anterior (a non-invasive test that doesn't require active participation by the patient) correlates with clinical whole-body weakness in critically ill patients admitted to an ICU with sepsis.

NCT ID: NCT04039620 Terminated - Sarcopenia Clinical Trials

EAMA Sarcopenia in Acute Care Patients in 9+European Countries

EAMA9+
Start date: March 6, 2019
Phase:
Study type: Observational

This collaborative study in 9 geriatrics units across Europe aims to apply emerging research to clinical practice, following the "Action-Research Philosophy" (11). The overall goal is to improve care in patients with - and help prevent - sarcopenia. Understanding the frequency of and risk factors for developing sarcopenia in an acute hospital setting, may help shed light on potential interventions and thus inform the development of future therapeutic strategies. It involves crucial implications for research, clinical practice, and policy towards optimal aging.

NCT ID: NCT03946709 Terminated - Sarcopenia Clinical Trials

Mirror Neurons in Older Participants

MNOP
Start date: December 20, 2018
Phase: N/A
Study type: Interventional

A critical problem facing aging adults is muscle weakness. Whereas scientists have traditionally attributed the loss of muscle strength with aging to muscle atrophy, emerging evidence suggests that impairments in the neuromuscular system's ability to voluntarily generate force plays a more central role than previously appreciated. One area that has not yet been investigated includes the role that observing another's actions - thereby activating mirror neurons - plays in muscle force generation. Therefore, the purpose of this study is to examine the acute effects of action observation on muscular strength, voluntary muscle activation, and cortical excitability and inhibition in older adults.